Prostacyclins are among the most potent and effective treatments for patients with advanced pulmonary arterial hypertension (PAH). This session will review currently available infused prostacyclin therapies, pros and cons of different modes of infusion systems, as well as their unique side effects.
Surgery and Anesthesia in PH Patients
The purpose of this session will be to review the potential risks of anesthesia and surgical procedures in patients with pulmonary hypertension.
Los Tratamientos que estan en Proceso de Desarrollarse
Durante esta sesion, el panel proporcionará una visión general de cómo se desarrollan los medicamentos, cómo los nuevos fármacos pueden afectar la selección de medicamentos,así como una visión general de los diversos ensayos clínicos en proceso y que han sido concluidos recientemente.
Goal-Directed Combination Therapy
The goal of this session is to discuss how combination therapy is used in pulmonary arterial hypertension (PAH). The concept of "goal-oriented therapy" will also be discussed.
Changes in therapy are usually considered when therapeutic goals are not reached or when medications are causing difficult side effects. We will discuss the monitoring that is often required before and after changes are made.
Drug Development, Treatments on the Horizon and Stem Cells
During this session, the panel provides an overview of how drugs are developed, how newer drugs may impact drug selection, as well as various active and recently completed clinical trials.
Exercise and Rehabilitation Programs
The goal of this session is to discuss how exercise and pulmonary rehab may affect pulmonary hypertension (PH) and how to incorporate regular exercise and rehab into your lifestyle. Specific focus will be on sharing the latest evidence of exercise benefit for PH, an tips on how to get started and stick with regular exercise programs for maximal benefit.